Works matching IS 03125963 AND DT 2024 AND VI 63 AND IP 4
Results: 10
Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 423, doi. 10.1007/s40262-024-01369-0
- By:
- Publication type:
- Article
Have We Neglected to Study Target-Site Drug Exposure in Children? A Systematic Review of the Literature.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 439, doi. 10.1007/s40262-024-01364-5
- By:
- Publication type:
- Article
Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 539, doi. 10.1007/s40262-024-01362-7
- By:
- Publication type:
- Article
Population Pharmacodynamic Dose–Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 551, doi. 10.1007/s40262-024-01360-9
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 397, doi. 10.1007/s40262-024-01355-6
- By:
- Publication type:
- Article
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 529, doi. 10.1007/s40262-024-01354-7
- By:
- Publication type:
- Article
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 483, doi. 10.1007/s40262-024-01352-9
- By:
- Publication type:
- Article
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 497, doi. 10.1007/s40262-024-01351-w
- By:
- Publication type:
- Article
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 469, doi. 10.1007/s40262-024-01350-x
- By:
- Publication type:
- Article
Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 511, doi. 10.1007/s40262-023-01340-5
- By:
- Publication type:
- Article